High-affinity interactions between human α1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the α1L-adrenoceptor

Molecular Pharmacology

Volumn 66, Issue 2, 2004, Pages 228-239

  Ramsay, Douglas ^a   Carr, I Craig ^a   Pediani, John ^a   Lopez Gimenez, Juan F ^a   Thurlow, Richard ^b   Fidock, Mark ^b   Milligan, Graeme ^a,c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1L ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; DELTA OPIATE RECEPTOR; DIMER; G PROTEIN COUPLED RECEPTOR; GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HYBRID PROTEIN; LUCIFERASE; OLIGOMER; PRAZOSIN; RADIOLIGAND; SULFUR 35; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIMERIZATION; DRUG BINDING SITE; EMBRYO; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; INTRACELLULAR MEMBRANE; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ALTERNATIVE SPLICING; CELLS, CULTURED; CLONING, MOLECULAR; DIMERIZATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; PROTEIN STRUCTURE, TERTIARY; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA-1; TIME FACTORS;

EID: 3342934656     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.66.2.228     Document Type: Article

References (44)

1. 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 97:3684-3689.
2. Ayoub MA, Couturier C, Lucas-Meunier E, Angers S, Fossier P, Bouvier M, and Jockers R (2002) Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem 277:21522-21528.
3. Baneres JL and Parello J (2003) Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 329:815-829.
4. Bockaert J, Marin P, Dumuis A, and Fagni L (2003) The 'magic tail' of G protein-coupled receptors: an anchorage for functional protein networks. FEBS Lett 546: 65-72.
5. Bourova L, Kostrnova A, Hejnova L, Moravcova Z, Moon HE, Novotny J, Milligan G, and Svoboda P (2003) delta-Opioid receptors exhibit high efficiency when activating trimeric G proteins in membrane domains. J Neurochem 85:34-49.
6. Bouvier M (2001) Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2:274-288.
7. Burt AR, Sautel M, Wilson MA, Rees S, Wise A, and Milligan G (1998) Agonist occupation of an α2A-adrenoreceptor-Gilα fusion protein results in activation of both receptor-linked and endogenous Gi proteins. Comparisons of their contributions to GTPase activity and signal transduction and analysis of receptor-G protein activation stoichiometry. J Biol Chem 273:10367-10375.
8. Carrillo JJ, Pediani J, and Milligan G (2003) Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. J Biol Chem 278:42578-42587.
9. 11. J Pharmacol Exp Ther 302:1080-1088.
10. 3H]pra-zosin binding and cellular trafficking of native human alpha1A-adrenoceptors. Biochem J 343:231-239.
11. Cvejic S and Devi LA (1997) Dimerization of the δ opioid receptor: implication for a role in receptor internalization. J Biol Chem 273: 26959-26964.
12. Daly CJ, Milligan CM, Milligan G, Mackenzie JF, and McGrath JC (1998) Cellular localization and pharmacological characterization of functioning alpha-1 adrenoceptors by fluorescent ligand binding and image analysis reveals identical binding properties of clustered and diffuse populations of receptors J Pharmacol Exp Ther 286:984-990.
13. Devi LA (2001) Heterodimerization of G protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol Sci 22:532-537.
14. Drmota T, Novotny J, Kim GD, Eidne KA, Milligan G, and Svoboda P (1998) Agonist-induced internalization of the G protein G11α and thyrotropin-releasing hormone receptors proceed on different time scales. J Biol Chem 273:21699-21707.
15. Eidne KA, Kroeger KM, and Hanyaloglu AC (2002) Applications of novel resonance energy transfer techniques to study dynamic hormone receptor interactions in living cells. Trends Endocrinol Metabol 13:415-421.
16. Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD, and Clarke DE (1997) Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 121:1127-1135.
17. Fredriksson R, Lagerstrom MC, Lundin LG, and Schioth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups and fingerprints. Mol Pharmacol 63:1256-1272.
18. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, and O'Dowd BF (2000) Oligomerization of μ- and δ-opioid receptors. J Biol Chem 275:26128-26135.
19. George SR, O'Dowd BF, and Lee SP (2002) G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 1:808-820.
20. Guo W, Shi L, and Javitch JA (2003) The fourth transmembrane segment forms the interface of the dopamine d2 receptor homodimer. J Biol Chem 278:4385-4388.
21. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271:16384-16392.
22. Hirasawa A, Sugawara T, Awaji T, Tsumaya K, Ito H, and Tsujimoto G (1997) Subtype-specific differences in subcellular localization of α1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype Mol Pharmacol 52:764-770.
23. Jordan BA and Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature (Lond) 399:697-700.
24. Jordan BA, Gomes I, Rios C, Filipovska J, and Devi LA (2003) Functional interactions between μ opioid and α2A-adrenergic receptors. Mol Pharmacol 64:1317-1324.
25. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, and Devi LA (2001) Oligomerization of opioid receptors with β2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci USA 98:343-348.
26. Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, and Engel A (2003) Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 278: 21655-21662.
27. Liu S, Carrillo JJ, Pediani J, and Milligan G (2002) Effective information transfer from the α1b-adrenoceptor to Gα 11 requires both β/γ interactions and an aromatic group four amino acids from the C terminus of the G protein J Biol Chem 277:25707-25714.
28. McVey M, Ramsay D, Kellett E, Rees S, Wilson S, Pope AJ, and Milligan G (2001) Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer: the human δ opioid receptor displays constitutive oligomerization at the cell surface which is not regulated by receptor occupancy. J Biol Chem 276:14092-14099.
29. 3 cells. Mol Pharmacol 59:774-783.
30. Mercier JF, Salahpour A, Angers S, Breit A, and Bouvier M (2002) Quantitative assessment of β1- and β2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277:44925-44931.
31. Milligan G (2001) Oligomerisation of G-protein-coupled receptors. J Cell Sci 114: 1265-1271.
32. 35S]GTP gamma S binding assays. Trends Pharmacol Sci 24:87-90.
33. Milligan G and White JH (2001) Protein-protein interactions at G-protein-coupled receptors. Trends Pharmacol Sci 22:513-518.
34. Mitchell FM, Buckley NJ, and Milligan G (1993) Enhanced degradation of the phosphoinositidase C-linked guanine-nucleotide-binding protein Gq alpha/G11 alpha following activation of the human M1 muscarinic acetylcholine receptor expressed in CHO cells. Biochem J 293:495-499.
35. Molinari P, Ambrosio C, Riitano D, Sbraccia M, Gro C, and Costa T (2003) Promiscuous coupling at receptor-Gα fusion proteins. The receptor of one covalent complex interacts with the α-subunit of another. J Biol Chem 278:15778-15788.
36. Overton MC and Blumer KJ (2002) The extracellular N-terminal domain and transmembrane domains 1 and 2 mediate oligomerization of a yeast G protein-coupled receptor. J Biol Chem 277:41463-41472.
37. Piascik MT and Perez DM (2001) αl-Adrenergic receptors: new insights and directions. J Pharmacol Exp Ther 298:403-410.
38. Pool JL and Kirby RS (2001) Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia. Int Urol Nephrol 33:407-412.
39. Ramsay D, Kellett E, McVey M, Rees S, and Milligan G (2002) Homo- and heterooligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem J 365:429-440.
40. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, and Patel YC (2000) Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science (Wash DC) 288:154-157.
41. Salim K, Fenton T, Bacha J, Urien-Rodriguez H, Bonnert T, Skynner HA, Watts E, Kerby J, Heald A, Beer M, et al. (2002) Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. J Biol Chem 277:15482-15485.
42. 1b-adrenergic receptor subtypes. J Biol Chem 278:40239-40251.
43. Uberti MA, Hall RA, and Minneman KP (2003) Subtype-specific dimerization of α1-adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 64:1379-1390.
44. 1-adrenergic receptor subtypes. J Pharmacol Exp Ther 302:58-65.